Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891020-99-000526
Filing Date
1999-03-25
Accepted
1999-03-25 00:00:00
Documents
7
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1998 10-K 178188
2 AMENDMENT 2 TO LEASE AGREEMENT EX-10.18A 2251
3 AMENDMENT 3 TO LEASE AGREEMENT EX-10.18B 5089
4 LOAN MODIFICATION AGREEMENT SEPTEMBER 21, 1997 EX-10.21A 18853
5 LOAN MODIFACATION AGREEMENT DATED AUGUST 31, 1998 EX-10.21B 4193
6 CONSENT OF ERNST & YOUNG EX-23.1 686
7 FINANCIAL DATA SCHEDULE EX-27.1 2149
  Complete submission text file 0000891020-99-000526.txt   213606
Mailing Address 22026 20TH AVENUE SE, SUITE 102 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21243 | Film No.: 99572488
SIC: 2835 In Vitro & In Vivo Diagnostic Substances